Global single cell multiomics market will reach $14,369.5 million by 2031, growing by 18.6% annually over 2021-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication.
Highlighted with 89 tables and 109 figures, this 207-page report “Global Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Region.
Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Consumables
• Software
Based on Omics Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Single Cell Genomics (SCG)
• Single Cell Transcriptomics (SCT)
• Single Cell Proteomics (SCP)
• Single Cell Metabolomics (SCM)
By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Clinical Research
o Oncology
o Cell Therapy
o Immunology
o Neurology
o Cell Biology
o Other Types of Clinical Research
• Translation Research
• Synthetic Biology
By Sample Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Human Samples
o Cancer Tissues
o Stem Cells
o Immune Cells
o Brain Cells
o Other Human Samples
• Animal Samples
• Microbial Samples
By Workflow, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Single-Cell Isolation and Dispensing
o Fluorescence-Activated Cell Sorting (FACS)
o Microfluidics
o Magnetic-Activated Cell Sorting (MACS)
o Random Seeding
o Manual Cell Picking
o Laser Capture Microdissection
o Other Technologies of Single-Cell Isolation and Dispensing
• Single-Cell Analysis
o Polymerase Chain Reaction
o Next-Generation Sequencing
o Mass Cytometry
o Mass Spectrometry
o Other Technologies of Single-Cell Analysis
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Research and Academic Laboratories
• Biopharmaceutical and Biotech Companies
• Contract Research Organizations (CROs)
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE，Saudi Arabia， South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Omics Type, Workflow and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
10x Genomics, Inc.
1CellBio, Inc.
Becton, Dickinson and Company
Berkeley Lights, Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioTuring, Inc.
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Fluidigm Corporation
Fluxion Biosciences
Illimina, Inc
Mission Bio, Inc.
Namocell, Inc.
NanoString Technologies, Inc.
Parse Biosciences, Inc.
Proteona
Qiagen N.V.
RareCyte, Inc.
Scipio Biosciences SAS
Shilps Sciences
Takara Bio Inc. (Takara Holdings)
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 11
1.1 Industry Definition and Research Scope 11
1.1.1 Industry Definition 11
1.1.2 Research Scope 12
1.2 Research Methodology 15
1.2.1 Overview of Market Research Methodology 15
1.2.2 Market Assumption 16
1.2.3 Secondary Data 16
1.2.4 Primary Data 16
1.2.5 Data Filtration and Model Design 17
1.2.6 Market Size/Share Estimation 18
1.2.7 Research Limitations 19
1.3 Executive Summary 20
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the Market 28
2.2 Major Growth Drivers 30
2.3 Market Restraints and Challenges 38
2.4 Emerging Opportunities and Market Trends 41
2.5 Porter’s Fiver Forces Analysis 45
3 Segmentation of Global Market by Product Type 49
3.1 Market Overview by Product Type 49
3.2 Instruments 51
3.3 Consumables 52
3.4 Software 53
4 Segmentation of Global Market by Omics Type 54
4.1 Market Overview by Omics Type 54
4.2 Single Cell Genomics (SCG) 56
4.3 Single Cell Transcriptomics (SCT) 57
4.4 Single Cell Proteomics (SCP) 58
4.5 Single Cell Metabolomics (SCM) 59
5 Segmentation of Global Market by Application 60
5.1 Market Overview by Application 60
5.2 Clinical Research 62
5.2.1 Oncology 64
5.2.2 Cell Therapy 65
5.2.3 Immunology 66
5.2.4 Neurology 67
5.2.5 Cell Biology 68
5.2.6 Other Types of Clinical Research 69
5.3 Translation Research 70
5.4 Synthetic Biology 71
6 Segmentation of Global Market by Sample Type 72
6.1 Market Overview by Sample Type 72
6.2 Human Samples 74
6.2.1 Cancer Tissues 76
6.2.2 Stem Cells 77
6.2.3 Immune Cells 78
6.2.4 Brain Cells 79
6.2.5 Other Human Samples 80
6.3 Animal Samples 81
6.4 Microbial Samples 82
7 Segmentation of Global Market by Workflow 83
7.1 Market Overview by Workflow 83
7.2 Single-Cell Isolation and Dispensing 85
7.2.1 Fluorescence-Activated Cell Sorting (FACS) 87
7.2.2 Microfluidics 88
7.2.3 Magnetic-Activated Cell Sorting (MACS) 89
7.2.4 Random Seeding 90
7.2.5 Manual Cell Picking 91
7.2.6 Laser Capture Microdissection 92
7.2.7 Other Technologies of Single-Cell Isolation and Dispensing 93
7.3 Single-Cell Analysis 94
7.3.1 Polymerase Chain Reaction 96
7.3.2 Next-Generation Sequencing 97
7.3.3 Mass Cytometry 98
7.3.4 Mass Spectrometry 99
7.3.5 Other Technologies of Single-Cell Analysis 100
8 Segmentation of Global Market by End User 101
8.1 Market Overview by End User 101
8.2 Research and Academic Laboratories 103
8.3 Biopharmaceutical and Biotech Companies 104
8.4 Contract Research Organizations (CROs) 105
8.5 Other End Users 106
9 Segmentation of Global Market by Region 107
9.1 Geographic Market Overview 2021-2031 107
9.2 North America Market 2021-2031 by Country 111
9.2.1 Overview of North America Market 111
9.2.2 U.S. 115
9.2.3 Canada 118
9.2.4 Mexico 120
9.3 European Market 2021-2031 by Country 122
9.3.1 Overview of European Market 122
9.3.2 Germany 126
9.3.3 U.K. 128
9.3.4 France 130
9.3.5 Spain 132
9.3.6 Italy 134
9.3.7 Netherlands 136
9.3.8 Rest of European Market 138
9.4 Asia-Pacific Market 2021-2031 by Country 140
9.4.1 Overview of Asia-Pacific Market 140
9.4.2 Japan 144
9.4.3 China 147
9.4.4 Australia 149
9.4.5 India 151
9.4.6 South Korea 153
9.4.7 Rest of APAC Region 155
9.5 South America Market 2021-2031 by Country 157
9.5.1 Argentina 160
9.5.2 Brazil 162
9.5.3 Chile 164
9.5.4 Rest of South America Market 166
9.6 MEA Market 2021-2031 by Country 167
9.6.1 UAE 170
9.6.2 Saudi Arabia 172
9.6.3 South Africa 174
9.6.4 Other National Markets 176
10 Competitive Landscape 177
10.1 Overview of Key Vendors 177
10.2 New Product Launch, Partnership, Investment, and M&A 181
10.3 Company Profiles 182
10x Genomics, Inc. 182
1CellBio, Inc. 184
Becton, Dickinson and Company 185
Berkeley Lights, Inc. 186
BGI Genomics Co., Ltd. 187
Bio-Rad Laboratories, Inc. 188
Bio-Techne Corporation 189
BioTuring, Inc. 190
Danaher Corporation (Cytiva Life Sciences) 191
Dolomite Bio 192
Fluidigm Corporation 193
Fluxion Biosciences 194
Illimina, Inc 195
Mission Bio, Inc. 196
Namocell, Inc. 197
NanoString Technologies, Inc. 198
Parse Biosciences, Inc. 199
Proteona 200
Qiagen N.V. 201
RareCyte, Inc. 202
Scipio Biosciences SAS 203
Shilps Sciences 204
Takara Bio Inc. (Takara Holdings) 205
Thermo Fisher Scientific Inc. 206
RELATED REPORTS 207
List of Tables:
Table 1. Snapshot of Global Single Cell Multiomics Market in Balanced Perspective, 2021-2031 21
Table 2. World Economic Outlook, 2021-2031 25
Table 3. World Economic Outlook, 2021-2023 26
Table 4. Comparison of Rare Disease in Different Countries 35
Table 5. World Health Spending by Region, $ bn, 2013-2020 37
Table 6. Main Product Trends and Market Opportunities in Global Single Cell Multiomics Market 41
Table 7. Global Single Cell Multiomics Market by Product Type, 2021-2031, $ mn 49
Table 8. Global Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 54
Table 9. Global Single Cell Multiomics Market by Application, 2021-2031, $ mn 60
Table 10. Global Single Cell Multiomics Market: Clinical Research by Type, 2021-2031, $ mn 63
Table 11. Global Single Cell Multiomics Market by Sample Type, 2021-2031, $ mn 72
Table 12. Global Single Cell Multiomics Market: Human Samples by Type, 2021-2031, $ mn 75
Table 13. Global Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 83
Table 14. Global Single Cell Multiomics Market: Single-Cell Isolation and Dispensing by Technology, 2021-2031, $ mn 86
Table 15. Global Single Cell Multiomics Market: Single-Cell Analysis by Technology, 2021-2031, $ mn 95
Table 16. Global Single Cell Multiomics Market by End User, 2021-2031, $ mn 101
Table 17. Global Single Cell Multiomics Market by Region, 2021-2031, $ mn 108
Table 18. Leading National Single Cell Multiomics Market, 2021 and 2031, $ mn 110
Table 19. North America Single Cell Multiomics Market by Country, 2021-2031, $ mn 113
Table 20. U.S. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 117
Table 21. U.S. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 117
Table 22. U.S. Single Cell Multiomics Market by End User, 2021-2031, $ mn 117
Table 23. Canada Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 119
Table 24. Canada Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 119
Table 25. Canada Single Cell Multiomics Market by End User, 2021-2031, $ mn 119
Table 26. Mexico Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 121
Table 27. Mexico Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 121
Table 28. Mexico Single Cell Multiomics Market by End User, 2021-2031, $ mn 121
Table 29. Europe Single Cell Multiomics Market by Country, 2021-2031, $ mn 125
Table 30. Germany Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 127
Table 31. Germany Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 127
Table 32. Germany Single Cell Multiomics Market by End User, 2021-2031, $ mn 127
Table 33. U.K. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 129
Table 34. U.K. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 129
Table 35. U.K. Single Cell Multiomics Market by End User, 2021-2031, $ mn 129
Table 36. France Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 131
Table 37. France Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 131
Table 38. France Single Cell Multiomics Market by End User, 2021-2031, $ mn 131
Table 39. Spain Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 133
Table 40. Spain Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 133
Table 41. Spain Single Cell Multiomics Market by End User, 2021-2031, $ mn 133
Table 42. Italy Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 135
Table 43. Italy Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 135
Table 44. Italy Single Cell Multiomics Market by End User, 2021-2031, $ mn 135
Table 45. Netherlands Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 137
Table 46. Netherlands Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 137
Table 47. Netherlands Single Cell Multiomics Market by End User, 2021-2031, $ mn 137
Table 48. Single Cell Multiomics Market in Rest of Europe by Country, 2021-2031, $ mn 139
Table 49. APAC Single Cell Multiomics Market by Country, 2021-2031, $ mn 142
Table 50. Japan Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 146
Table 51. Japan Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 146
Table 52. Japan Single Cell Multiomics Market by End User, 2021-2031, $ mn 146
Table 53. China Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 148
Table 54. China Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 148
Table 55. China Single Cell Multiomics Market by End User, 2021-2031, $ mn 148
Table 56. Australia Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 150
Table 57. Australia Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 150
Table 58. Australia Single Cell Multiomics Market by End User, 2021-2031, $ mn 150
Table 59. India Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 152
Table 60. India Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 152
Table 61. India Single Cell Multiomics Market by End User, 2021-2031, $ mn 152
Table 62. South Korea Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 154
Table 63. South Korea Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 154
Table 64. South Korea Single Cell Multiomics Market by End User, 2021-2031, $ mn 154
Table 65. Single Cell Multiomics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 156
Table 66. South America Single Cell Multiomics Market by Country, 2021-2031, $ mn 159
Table 67. Argentina Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 161
Table 68. Argentina Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 161
Table 69. Argentina Single Cell Multiomics Market by End User, 2021-2031, $ mn 161
Table 70. Brazil Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 163
Table 71. Brazil Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 163
Table 72. Brazil Single Cell Multiomics Market by End User, 2021-2031, $ mn 163
Table 73. Chile Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 165
Table 74. Chile Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 165
Table 75. Chile Single Cell Multiomics Market by End User, 2021-2031, $ mn 165
Table 76. MEA Single Cell Multiomics Market by Country, 2021-2031, $ mn 169
Table 77. UAE Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 171
Table 78. UAE Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 171
Table 79. UAE Single Cell Multiomics Market by End User, 2021-2031, $ mn 171
Table 80. Saudi Arabia Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 173
Table 81. Saudi Arabia Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 173
Table 82. Saudi Arabia Single Cell Multiomics Market by End User, 2021-2031, $ mn 173
Table 83. South Africa Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 175
Table 84. South Africa Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 175
Table 85. South Africa Single Cell Multiomics Market by End User, 2021-2031, $ mn 175
Table 86. Breakdown of World Market by Key Vendor, 2020, % 179
Table 87. 10x Genomics, Inc.: Company Snapshot 182
Table 88. 10x Genomics, Inc.: Business Segmentation 183
Table 89. 10x Genomics, Inc.: Product Portfolio 183
